User contributions for Tejasvi Aryaputra
Jump to navigation
Jump to search
7 February 2023
- 23:0723:07, 7 February 2023 diff hist +15,078 Lybalvi (Olanzapine and Samidorphan) No edit summary current
20 January 2023
- 17:0117:01, 20 January 2023 diff hist +3,741 N Lybalvi (Olanzapine and Samidorphan) Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Lybalvi |aOrAn=a |drugClass=combination of olanzapine, an atypical antipsychotic, and samidorphan, an opioid antagonist |indicationType=treatment |indication=schizophrenia and certain aspects of bipolar I disorder |hasBlackBoxWarning=Yes |adverseReactions=somnolence, headache, [[dry mouth], and weight increase for patients with schizophrenia. Dizziness, asthenia, constipation, [..."
- 16:1016:10, 20 January 2023 diff hist 0 N File:Package Insert Pt.2.png No edit summary current
- 16:1016:10, 20 January 2023 diff hist 0 N File:Package Insert Pt.1.png No edit summary current
- 16:1016:10, 20 January 2023 diff hist 0 N File:Drug Label 2.png No edit summary current
- 16:1016:10, 20 January 2023 diff hist 0 N File:Drug Label 1.png No edit summary current
- 16:1016:10, 20 January 2023 diff hist 0 N File:Drug Info.png No edit summary current
- 16:1016:10, 20 January 2023 diff hist 0 N File:Structure 2.png No edit summary current
- 16:0916:09, 20 January 2023 diff hist 0 N File:Structure 1.png No edit summary current
- 16:0916:09, 20 January 2023 diff hist 0 N File:Table 5 Clinical Data Trial 3.png No edit summary current
- 16:0916:09, 20 January 2023 diff hist 0 N File:Table 4 Clinical Data Trial 1 and 2.png No edit summary current
- 16:0916:09, 20 January 2023 diff hist 0 N File:Table 3 Coadmininstered Drugs.png No edit summary current
- 16:0916:09, 20 January 2023 diff hist 0 N File:Table 2 Adverse Reaction Trial 3.png No edit summary current
- 16:0916:09, 20 January 2023 diff hist 0 N File:Ibrexafungerp Table 1 Adverse Reactions (Trials 1 and 2).png No edit summary current
- 15:5115:51, 20 January 2023 diff hist +5,623 Ibrexafungerp No edit summary current
18 January 2023
- 06:0006:00, 18 January 2023 diff hist +4,749 Ibrexafungerp No edit summary
- 04:5604:56, 18 January 2023 diff hist +2,856 Aducanumab-avwa No edit summary current
- 04:5404:54, 18 January 2023 diff hist +2,211 Aducanumab-avwa No edit summary
11 January 2023
- 05:4805:48, 11 January 2023 diff hist +8,233 N Ibrexafungerp Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Ibrexafungerp |aOrAn=a |drugClass=triterpenoid antifungal |indicationType=treatment |indication=vulvovaginal candidiasis |hasBlackBoxWarning=Yes |adverseReactions=nausea, dizziness, diarrhea, vomiting, and abdominal pain |blackBoxWarningTitle='''<span style="color:#FF0000;">RISK OF EMBRYO-FETAL TOXICITY</span>''' |blackBoxWarningBody=<BR> *BREXAFEMME is contraindicated in pregn..."
10 January 2023
- 21:5921:59, 10 January 2023 diff hist 0 N File:Aducanumab-avwa Table 8 Study 2 Biomarkers.png No edit summary current